For the Quarter Ending March 2026
Cefpodoxime Proxetil Prices in APAC
- In China, the Cefpodoxime Proxetil Price Index rose by 4.05% quarter-over-quarter, due to export constraints.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1068360.00/MT FOB Shanghai basis.
- Cefpodoxime Proxetil Spot Price tightened as energy controls reduced spot availability and accelerated forward bookings.
- Cefpodoxime Proxetil Price Forecast indicates slight upward pressure from export restocking and limited spot availability.
- Cefpodoxime Proxetil Production Cost Trend stayed contained due to in-house fermentation and stable intermediate pricing.
- Cefpodoxime Proxetil Demand Outlook remains firm with NRDL-supported hospital purchases and steady overseas tender volumes.
- Cefpodoxime Proxetil Price Index jumped in March reflecting batch-release delays, tightened 7-ACA supply, and bookings.
- Inventories stayed near four-week norms, limiting volatility while exporters honoured contracts sustaining steady netbacks abroad
Why did the price of Cefpodoxime Proxetil change in March 2026 in APAC?
- Dual-control energy directives reduced operating days at Jiangsu and Zhejiang plants, cutting exportable API output.
- Intensified batch inspections constrained 7-ACA and batch clearing, raising short-term raw-material tightness and pricing pressure.
- Export bookings from India and Brazil absorbed half output, amplifying price response amid limited availability.
Cefpodoxime Proxetil Prices in Europe
- In Germany, the Cefpodoxime Proxetil Price Index rose by 4.05% quarter-over-quarter, driven by firmer FOB.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1068484.67/MT on CFR Hamburg.
- Cefpodoxime Proxetil Spot Price tightened as Indian and Chinese offers firmed, elevating landed import costs.
- Cefpodoxime Proxetil Price Forecast projects mild gains as distributors replenish inventories after a stable winter.
- Cefpodoxime Proxetil Production Cost Trend showed stable energy tariffs but firmer upstream intermediate pricing pressures.
- Cefpodoxime Proxetil Demand Outlook remained balanced with routine pharmacy, hospital procurement and contractual export volumes.
- Cefpodoxime Proxetil Price Index spiked in March following Chinese audits and German wholesalers' precautionary restocking.
- Inventory buffers and container availability prevented immediate shortages despite higher freight exposure and tightened offers.
Why did the price of Cefpodoxime Proxetil change in March 2026 in Europe?
- Chinese export allocations were reduced, tightening physical availability and materially raising landed CFR Hamburg prices.
- Euro weakened against the dollar, mechanically increasing import costs and elevating euro-denominated reimbursement pressures further.
- German wholesalers restocked ahead of contract awards, generating additional buying pressure and amplifying the rally
Cefpodoxime Proxetil Prices in North America
- In USA, the Cefpodoxime Proxetil Price Index rose by 4.05% quarter-over-quarter, driven by higher freight.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1068525/MT, reflecting spot trade.
- Cefpodoxime Proxetil Spot Price advanced with container rates increasing, compressing lots and tightening spot availability.
- Cefpodoxime Proxetil Price Forecast indicates modest upward trajectory as distributors replenish inventories amid stable baseline demand.
- Cefpodoxime Proxetil Production Cost Trend reflected higher landed costs from freight and tariffs, narrowing margins.
- Cefpodoxime Proxetil Demand Outlook remains steady with routine paediatric and hospital procurement supporting measured offtake.
- Cefpodoxime Proxetil Price Index movements were driven primarily by logistics inflation rather than upstream manufacturing disruptions.
- Distributors reported comfortable inventories, limiting sellers leverage despite incremental cost pass-through and disciplined exporter batch releases.
Why did the price of Cefpodoxime Proxetil change in March 2026 in North America?
- Rising Asia-U.S. freight elevated landed costs, directly pressuring import price levels.
- Distributor restocking and synchronized contract call-offs increased demand, reducing available spot lots and amplifying price response.
- Port operations remained fluid but freight spikes and insurance premiums tightened supply chains, triggering short-term price increases.
For the Quarter Ending December 2025
Cefpodoxime Proxetil Prices in North America
- In USA, the Cefpodoxime Proxetil Price Index rose by 1.81% quarter-over-quarter, driven by supply tightness.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1026930.00/MT, reflecting strong import demand.
- Cefpodoxime Proxetil Spot Price movements moderated in December as freight declines offset tariff and procurement pressures.
- Cefpodoxime Proxetil Price Forecast points to modest upward bias into early 2026 amid steady demand and logistical costs.
- Cefpodoxime Proxetil Production Cost Trend showed pressure from higher feedstock and compliance costs in exporting countries.
- Cefpodoxime Proxetil Demand Outlook remains firm with seasonal respiratory infections supporting sustained generic manufacturer buying.
- Cefpodoxime Proxetil Price Index reflected balanced supply as inventories remained comfortable and exports did not spike.
- Major API producers maintained shipments despite intermittent regulatory scrutiny, keeping supply channels open and limiting price volatility.
Why did the price of Cefpodoxime Proxetil change in December 2025 in North America?
- Production constraints and environmental compliance in exporters limited effective supply, tightening available API for U.S. buyers.
- Freight volatility and freight rate declines partially offset costs, but tariffs and insurance sustained landed cost pressures.
- Steady formulation demand and distributor restocking maintained consumption, preventing significant price declines despite logistical easing.
Cefpodoxime Proxetil Prices in APAC
- In China, the Cefpodoxime Proxetil Price Index rose by 1.81% quarter-over-quarter, supported by constrained supply.
- The average Cefpodoxime Proxetil price for the quarter was USD 1026780.00/MT, Shanghai FOB this quarter.
- Cefpodoxime Proxetil Spot Price remained range-bound as precautionary buying matched available limited export volumes consistently.
- Cefpodoxime Proxetil Price Forecast suggests gains; Cefpodoxime Proxetil Production Cost Trend shows elevation from energy and intermediates.
- Cefpodoxime Proxetil Demand Outlook stays firm with seasonal respiratory consumption supporting China Price Index stability.
- Inventory at manufacturers tightened, pressuring pricing as Cefpodoxime Proxetil Price Index reacted to lower lots.
- Port operations eased, reducing congestion and supporting shipments, tempering upward Cefpodoxime Proxetil Spot Price pressure.
- Major plants maintained run-rates with limited maintenance, enabling steady exports and modest Price Index uplift.
Why did the price of Cefpodoxime Proxetil change in December 2025 in APAC?
- Logistics disruptions and elevated freight raised landed costs, tightening supply and supporting December price uptick.
- Stable plant run-rates and sufficient intermediates prevented sharp shortages, keeping prices balanced despite export restocking.
- Domestic procurement limits under stewardship capped hospital purchases, moderating demand growth and limiting price upside.
Cefpodoxime Proxetil Prices in Europe
- In Germany, Cefpodoxime Proxetil Price Index rose by 1.81% quarter-over-quarter, driven by logistics and restocking during Q4.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1026880.00/MT, CFR Hamburg assessed.
- Elevated freight costs and port congestion pushed the Cefpodoxime Proxetil Spot Price higher for importers.
- Near-term Cefpodoxime Proxetil Price Forecast suggests modest increases as logistical premiums persist into next year.
- Higher energy and transport inputs raised the Cefpodoxime Proxetil Production Cost Trend for API shipments.
- Seasonal infection risks and tender timings shaped the Cefpodoxime Proxetil Demand Outlook for formulators domestically.
- Distributor inventory buffers limited spot buying, keeping the Cefpodoxime Proxetil Price Index broadly orderly recently.
- Export demand from neighbouring markets and contract renewals modestly supported landed price levels for Germany
Why did the price of Cefpodoxime Proxetil change in December 2025 in Europe?
- Freight stability and steady origin offers left landed costs unchanged for German importers in December.
- Balanced tender schedules and routine formulators' call-offs prevented spot buying surges, moderating December price movements.
- No significant production outages and stable currency translation limited upward pressure on CFR landed values.
For the Quarter Ending September 2025
North America
- In USA, the Cefpodoxime Proxetil Price Index rose 2.57% QoQ, Q3 2025, amid import cost pressures and tariff risk.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1,008,686 per metric ton.
- Cefpodoxime Proxetil Spot Price remained elevated due to tight supply, front-loading by buyers, and logistical delays.
- Cefpodoxime Proxetil Price Forecast incorporated expectations of persistent demand, tariff uncertainty, and evolving port congestion in the region.
- Cefpodoxime Proxetil Production Cost Trend moved higher on freight surcharges, energy costs, and tighter intermediate pricing.
- Cefpodoxime Proxetil Demand Outlook remains robust in US pharmaceutical markets, supporting steady import volumes and price resilience.
- Cefpodoxime Proxetil Price Index signals ongoing pricing power amid supply tightness, logistics costs, and policy risk.
- Cefpodoxime Proxetil Spot Price volatility supports strategic stockpiling and margin protection for distributors amid volatility.
Why did the price of Cefpodoxime Proxetil change in September 2025 in North America?
- Supply disruptions and tariff anticipation boosted inbound volumes and port congestion in September 2025.
- Rising freight and handling costs increased landed prices for CFR Houston shipments, reinforcing price momentum.
- Seasonal demand and stockpiling by hospitals and distributors supported sustained pricing pressure through Q3 2025.
APAC
- In China, the Cefpodoxime Proxetil Price Index rose 2.61% QoQ due to cost pressures and tight supply.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1,008,536/MT, reflecting firm market tone.
- Cefpodoxime Proxetil Spot Price remained elevated amid ongoing supply tightness and steady, if selective, demand recovery.
- Cefpodoxime Proxetil Price Forecast points to limited upside unless new supply sources materialize promptly.
- Cefpodoxime Proxetil Production Cost Trend remains elevated as raw materials and energy costs persist.
- Cefpodoxime Proxetil Demand Outlook is positive in regional pharma markets, underpinning price resilience for regional markets.
- Cefpodoxime Proxetil Price Index continues to reflect logistics challenges and currency volatility on balance.
- Cefpodoxime Proxetil Spot Price dynamics align with seasonal restocking and tender-driven demand shifts in APAC.
- Cefpodoxime Proxetil Price Forecast, Production Cost Trend, and Demand Outlook collectively steer market direction amid price stability signals.
- Why did the price of Cefpodoxime Proxetil change in September 2025 in APAC?
- Supply tightness and factory maintenance constrained output, supporting higher price levels.
- Rising input costs and freight charges kept production costs elevated, reinforcing price momentum.
- Logistics disruptions and tariff uncertainties weighed on supply chains, contributing to price resilience.
Europe
- In Germany, the Cefpodoxime Proxetil Price Index rose by 2.60% quarter-over-quarter, buoyed by logistics constraints in Q3 2025.
- The average Cefpodoxime Proxetil price for the quarter was approximately USD 1,008,636/MT.
- Cefpodoxime Proxetil Spot Price remained elevated amid import tightness and persistent supplier constraints and regional bottlenecks.
- Cefpodoxime Proxetil Price Forecast suggests cautious upside due to ongoing supply chain disruptions.
- Cefpodoxime Proxetil Production Cost Trend points to higher landed costs in Germany driven by energy and logistics.
- Cefpodoxime Proxetil Demand Outlook remains robust from pharma manufacturers and healthcare distributors amid steady uptake.
- Cefpodoxime Proxetil Price Index shows continued sensitivity to euro-dollar fluctuations and import costs.
- Cefpodoxime Proxetil Spot Price volatility reflects seasonal demand shifts and carrier capacity constraints.
- Prices remain within established range as buyers adjust procurement, maintaining supply security strategically.
Why did the price of Cefpodoxime Proxetil change in September 2025 in Europe?
- Ongoing logistics bottlenecks and port disruptions raised landed costs for Cefpodoxime Proxetil imports across Europe.
- Rising freight rates and currency fluctuations further weighed on EU import expenditures for Cefpodoxime Proxetil.
- Steady pharmaceutical demand supported pricing resilience despite softer macro signals and competitive market dynamics.
For the Quarter Ending June 2025
North America
- The Cefpodoxime Proxetil market in North America experienced an overall stable-to-upward trend during Q2 2025, with an average quarter-over-quarter price change close to +0.3%; spot price index ended June near 986,450 USD per unit, reflecting a steady upward trajectory from the low observed in April.
- In June 2025, Cefpodoxime Proxetil spot prices climbed notably as robust pharmaceutical demand surged amid infection peaks, compounded by supply constraints due to Chinese factory shutdowns and tariff-driven stockpiling; these factors drove landed costs higher despite smooth logistics overall.
- Cefpodoxime Proxetil Production cost trends in Q2 reflected increased global input prices, including fermentation substrates and energy, particularly impacting Chinese and Brazilian producers, thus feeding into North American import prices during May and June.
- The Cefpodoxime Proxetil demand outlook strengthened notably in late spring, fueled by seasonal infectious disease upticks driving hospitals, generic drug manufacturers, and veterinary sectors to increase procurement and inventory replenishment.
- Amid continuing tariff uncertainty and U.S.-China trade tensions, importers adopted strategic frontloading behaviors in May and June, exacerbating supply tightness and underpinning price gains in the quarter’s second half.
- April saw downward pressures with aggressive discounting from Chinese exporters responding to steep U.S tariffs and temporary stockpiling by importers that suppressed new orders, reflecting a muted demand environment and abundant inventories.
- Freight challenges including increased container imbalances and higher ocean freight rates through May elevated landed costs, reinforcing cost pass-through to end-users and dampening margin flexibility across the supply chain.
- Domestic U.S. Cefpodoxime Proxetil supply remained stable with no shortage issues, but buyer hesitancy during April and early May restrained demand, keeping prices subdued before the seasonal rebound.
- Forward-looking price forecasts for Q3 anticipate sustained upward momentum driven by continuing supply restrictions overseas, higher production cost inflation, and resilient healthcare demand.
- Overall, the interplay of global production bottlenecks, logistics complexities, tariff-driven procurement patterns, and strong late-quarter demand resulted in a cautiously bullish Cefpodoxime Proxetil pricing environment across North America in Q2 2025.
Asia-Pacific (APAC)
- The APAC Cefpodoxime Proxetil spot price index for Q2 2025 moved from downward pressure in April, averaging a modest 0.23% quarterly increase with prices ending June on an upward slope around 985,000 CNY equivalent, driven by supply constraints and firm demand.
- June 2025 marked a pronounced price rise, influenced by sustained factory shutdowns in China due to environmental audits, higher input costs, and increased global antibiotic demand from Southeast Asia and beyond.
- Production cost trends within the quarter's second half sharply increased as compliance measures, energy rationing, and regulatory inspections constrained output, thereby tightening supply availability.
- Cefpodoxime Proxetil Demand outlook improved markedly in May and June, bolstered by higher respiratory infection rates and increased procurement activity from Latin America, Middle Eastern, and African markets as well as regional formulators.
- Early quarter oversupply conditions reversed as export volumes tightened with staggered suspension of major Chinese API plants, creating intermittent shortages and elevating global market prices.
- Logistical challenges such as port congestion at Ningbo and Shanghai, container shortages, and shipping cost inflation contributed to higher landed costs, incentivizing exporters to raise Cefpodoxime Proxetil export prices.
- Currency fluctuations, particularly yuan volatility coupled with stricter customs controls on beta-lactam APIs, increased transactional costs and administrative burdens affecting APAC market dynamics.
- Bulk purchasing ahead of anticipated Q3 regulatory reforms on API traceability further accelerated demand and price firming in June, highlighting strategic buyer behaviors reacting to supply uncertainties.
- Cefpodoxime Proxetil Price forecasts for the next quarter suggest continuing upward pressure if environmental policies and global demand imbalances persist, potentially leading to further EUR/USD and USD/CNY exchange rate sensitivities influencing spot prices.
- Overall, APAC’s Q2 2025 Cefpodoxime Proxetil market demonstrated a transition from oversupply-driven weakness to a supply-constrained, demand-driven rally, emphasizing the region’s critical role in balancing global API supply chains.
Europe
- Europe’s Cefpodoxime Proxetil spot price index in Q2 2025 averaged a mild upward price change near 0.25%, with June prices climbing steadily due to tightened global supply and firm demand, culminating near 985,500 EUR per unit.
- In June 2025, price escalation was underpinned by increased global production costs mainly from China and intensified logistical hurdles at major ports like Hamburg and Rotterdam, alongside strong pharmaceutical and healthcare sector demand in Germany.
- Cefpodoxime Proxetil Production cost trends in Europe showed upward pressure reflecting higher energy tariffs, stringent environmental regulations in key producing countries, and costly fermentation process inputs exacerbated through Q2.
- The Cefpodoxime Proxetil demand outlook remained robust; German pharmaceutical companies and distributors increased restocking efforts anticipating Q3 supply constraints and ongoing infection-driven antibiotic needs.
- April experienced price declines from oversupply due to increased Asian exports and strategic stockpiling, but subdued short-term demand prompted buyers to delay retriggering upward price trends in May and June.
- Supply chain disruptions, including port congestion and inland transport bottlenecks, elevated freight and delivery costs, which were passed on through rising Cefpodoxime Proxetil import prices in the European market.
- The euro’s appreciation against the U.S. dollar temporarily eased procurement costs but was insufficient to offset strong global cost inflation and higher landed costs in June.
- German and European buyers adapted procurement cycles to anticipate further price rises and extended lead times, intensifying purchasing activity during May and June.
- Cefpodoxime Proxetil Price forecasts for the next quarter indicate sustained upward momentum driven by production compliance challenges overseas, ongoing shipping constraints, and stable-to-increasing pharmaceutical demand across Europe.
- Collectively, the European market navigated from a supply-driven discount phase in April to a demand and cost-influenced price recovery in Q2 2025, highlighting regional sensitivities to global supply chain shifts and cost inflation pressures impacting Cefpodoxime Proxetil prices.
